CUE-69429-66000
4 vaccinations
3 coded responses
35 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 480 / MI
- Registered
- 2021-11-05
- Relationship
- Child or adolescent in my care
- Guardian
- DBY-20625-57500
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-04
Dose 1 — Pfizer-BioNTech
-
2021-11-05
Registered in v-safe
-
2021-11-05
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-11
- 2021-11-18
- 2021-11-25
-
2021-11-26
Dose 2 — Pfizer-BioNTech
-
2021-11-27
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-11-29
- 2021-11-30
- 2021-12-01
- 2021-12-03
- 2021-12-11
- 2021-12-18
- 2021-12-24
- 2021-12-31
- 2022-01-07
- 2022-02-25
-
2022-05-20
Dose 3 — Pfizer-BioNTech
- 2022-05-20
- 2022-05-21
- 2022-05-22
- 2022-05-24
- 2022-05-26
- 2022-05-27
-
2022-06-03
Survey response — day 14, dose 3, dependentMedDRA: Influenza virus test negative, SARS-CoV-2 test negative, Viral infection, Vomiting — Feeling: Good · Be unable to work or attend schoolFree text: Viral infection. Throwing up multiple times over six hours. No fever. Resolved within 24 hours. SARS-Cov-2 and flu PCR negative. SARS-Cov-2 antigen test negative.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-12
- 2022-06-17
- 2022-06-24
- 2022-07-02
- 2022-08-19
-
2022-11-18
Survey response — 6 months, dose 3, dependentMedDRA: Cough, Oropharyngeal pain, Rhinorrhoea — Feeling: GoodFree text: Runny nose, sore throat, light coughMedDRA releases: 2024-11 · check-in free text available
-
2022-12-09
Dose 4 — Pfizer-BioNTech
- 2023-01-13
-
2023-01-20
Survey response — day 42, dose 4, dependentMedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: GoodMedDRA releases: 2024-11
- 2023-03-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-04 | Pfizer-BioNTech | No |
| 2 | 2021-11-26 | Pfizer-BioNTech | No |
| 3 | 2022-05-20 | Pfizer-BioNTech | No |
| 4 | 2022-12-09 | Pfizer-BioNTech | No |
Free text
Release 11 — day 14, dose 3, dependent
Symptoms: Viral infection. Throwing up multiple times over six hours. No fever. Resolved within 24 hours. SARS-Cov-2 and flu PCR negative. SARS-Cov-2 antigen test negative.
Release 12 — 6 months, dose 3, dependent
Symptoms: Runny nose, sore throat, light cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Influenza virus test negative | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release